via University at Buffalo
Model could support the assessment of long-term chronic drug therapies and help clinicians develop more effective treatments for complex diseases
Using artificial intelligence, a team of University at Buffalo researchers has developed a novel system that models the progression of chronic diseases as patients age.
Published in Oct. in the Journal of Pharmacokinetics and Pharmacodynamics, the model assesses metabolic and cardiovascular biomarkers – measurable biological processes such as cholesterol levels, body mass index, glucose and blood pressure – to calculate health status and disease risks across a patient’s lifespan.
The findings are critical due to the increased risk of developing metabolic and cardiovascular diseases with aging, a process that has adverse effects on cellular, psychological and behavioral processes.
“There is an unmet need for scalable approaches that can provide guidance for pharmaceutical care across the lifespan in the presence of aging and chronic co-morbidities,” says lead author Murali Ramanathan, PhD, professor of pharmaceutical sciences in the UB School of Pharmacy and Pharmaceutical Sciences. “This knowledge gap may be potentially bridged by innovative disease progression modeling.”
The model could facilitate the assessment of long-term chronic drug therapies, and help clinicians monitor treatment responses for conditions such as diabetes, high cholesterol and high blood pressure, which become more frequent with age, says Ramanathan.
Additional investigators include first author and UB School of Pharmacy and Pharmaceutical Sciences alumnus Mason McComb, PhD; Rachael Hageman Blair, PhD, associate professor of biostatistics in the UB School of Public Health and Health Professions; and Martin Lysy, PhD, associate professor of statistics and actuarial science at the University of Waterloo.
The research examined data from three case studies within the third National Health and Nutrition Examination Survey (NHANES) that assessed the metabolic and cardiovascular biomarkers of nearly 40,000 people in the United States.
Biomarkers, which also include measurements such as temperature, body weight and height, are used to diagnose, treat and monitor overall health and numerous diseases.
The researchers examined seven metabolic biomarkers: body mass index, waist-to-hip ratio, total cholesterol, high-density lipoprotein cholesterol, triglycerides, glucose and glycohemoglobin. The cardiovascular biomarkers examined include systolic and diastolic blood pressure, pulse rate and homocysteine.
By analyzing changes in metabolic and cardiovascular biomarkers, the model “learns” how aging affects these measurements. With machine learning, the system uses a memory of previous biomarker levels to predict future measurements, which ultimately reveal how metabolic and cardiovascular diseases progress over time.
Original Article: AI-powered computer model predicts disease progression during aging
More from: University at Buffalo | University of Waterloo
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Long-term chronic drug therapies
- A Predictive Healthcare Visionary Is Optimistic About Solving America’s Opioid Addiction And Chronic Pain Epidemic
Studies found that Chronic pain is more prevalent and costly than cancer, diabetes, and heart disease combined, and its rates are rising even as other chronic ...
- Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose
Ten years after dipping its toe into the gene therapy pool in a licensing deal with Spark Therapeutics, Pfizer has gained an FDA approval for the acquired treatment. | Ten years after dipping its toe ...
- FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.
- A Proven Model to Combat U.S. Drug Shortages
Drug shortages continue to plague the United States. In many ways, the problem is the result of deficiencies in the current pharma market. But a model for addressing this problem is showing that it ...
- What Are the Most Effective Psoriasis Therapy Options?
With many treatment options for psoriasis, how do you know which ones are right for you? Here are the most effective psoriasis therapy options to consider.
Go deeper with Google Headlines on:
Long-term chronic drug therapies
[google_news title=”” keyword=”long-term chronic drug therapies” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Progression of chronic diseases
- Rare and fatal brain disease in two deer hunters heightens concerns about CWD
A team of researchers at University of Texas Health Science Center said the cases hint at a potential contamination from infected venison. The Centers for Disease Control (CDC) says link is unlikely.
- Drop in Chronic Kidney Disease in Type 2 Diabetes seen with new drug
A medical expert is optimistic about the potential drop in the progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) cases in the country over the next five to 10 years. Dr. Ronald ...
- Epidemiology and Survival of the Five Stages of Chronic Kidney Disease in a Systolic Heart Failure Population
Aims The epidemiology of the five stages of chronic kidney disease (CKD) in systolic heart failure (HF) patients has predominantly been described in hospitalized White patients, with little known ...
- Carbon beads may help reduce liver disease, restore gut health
New research shows that innovative carbon beads — which are capable of absorbing harmful bacteria and toxins — could improve gut health, and reduce the progression of liver disease.
- Parkinson's disease progression slowed by antibody infusions
Monthly infusions with the drug prasinezumab appeared to slow the progression of motor symptoms in people with advanced Parkinson's disease ...
Go deeper with Google Headlines on:
Progression of chronic diseases
[google_news title=”” keyword=”progression of chronic diseases” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]